PMC:7156806 / 6580-6900 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T39","span":{"begin":49,"end":67},"obj":"CHEBI:5801;DG_20;CHEBI:5801"},{"id":"T40","span":{"begin":75,"end":87},"obj":"CHEBI:2955;DG_6;CHEBI:2955"},{"id":"T41","span":{"begin":170,"end":178},"obj":"SP_7"},{"id":"T2390","span":{"begin":49,"end":67},"obj":"CHEBI:5801;DG_20;CHEBI:5801"},{"id":"T61512","span":{"begin":75,"end":87},"obj":"CHEBI:2955;DG_6;CHEBI:2955"},{"id":"T99933","span":{"begin":170,"end":178},"obj":"SP_7"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T42","span":{"begin":170,"end":178},"obj":"Disease"}],"attributes":[{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T30","span":{"begin":156,"end":157},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":49,"end":67},"obj":"Chemical"},{"id":"T7","span":{"begin":75,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T50","span":{"begin":189,"end":309},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"111","span":{"begin":144,"end":152},"obj":"Species"},{"id":"112","span":{"begin":49,"end":67},"obj":"Chemical"},{"id":"113","span":{"begin":75,"end":87},"obj":"Chemical"},{"id":"125","span":{"begin":170,"end":178},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"tao:has_database_id","subj":"111","obj":"Tax:9606"},{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"MESH:D006886"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"MESH:D017963"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital.\nFour hundred and forty-three (64% of the 692 who answered this question) worked in an inpatient rehabilitation facility. When asked"}